Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activation

Gut

Volumn 65, Issue 5, 2016, Pages 777-787

  Matsukawa, Toshihiro ^a,b   Izawa, Kumi ^b,c   Isobe, Masamichi ^b   Takahashi, Mariko ^b   Maehara, Akie ^b   Yamanishi, Yoshinori ^b   Kaitani, Ayako ^b   Okumura, Ko ^c   Teshima, Takanori ^a   Kitamura, Toshio ^b   Kitaura, Jiro ^b,c  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BINDING PROTEIN; CD300F PROTEIN; CERAMIDE; HYBRID PROTEIN; UNCLASSIFIED DRUG; CLM-1 PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CELL POPULATION; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL COLITIS; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY CELL; LAMINA PROPRIA; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; COLITIS; DISEASE MODEL; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; ANIMALS; CERAMIDES; COLITIS; DISEASE MODELS, ANIMAL; MAST CELLS; MICE; MICE, INBRED C57BL; RECEPTORS, IMMUNOLOGIC;

EID: 84930035671     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-308900     Document Type: Article

References (26)

1. Cader MZ, Kaser A. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut 2013;62:1653-64.
2. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010;28:573-621.
3. Saleh M, Trinchieri G. Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat Rev Immunol 2011;11:9-20.
4. Fukata M, Arditi M. The role of pattern recognition receptors in intestinal inflammation. Mucosal Immunol 2013;6:451-63.
5. Wirtz S, Neufert C, Weigmann B, et al. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007;2:541-6.
6. Cooper HS, Murthy SN, Shah RS, et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238-49.
7. Rijnierse A, Koster AS, Nijkamp FP, et al. Critical role for mast cells in the pathogenesis of 2, 4-dinitrobenzene-induced murine colonic hypersensitivity reaction. J Immunol 2006;176:4375-84.
8. Kurashima Y, Amiya T, Nochi T, et al. Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors. Nat Commun 2012;3:1034.
9. Hamilton MJ, Sinnamon MJ, Lyng GD, et al. Essential role for mast cell tryptase in acute experimental colitis. Proc Natl Acad Sci USA 2011;108:290-5.
10. Waddell A, Ahrens R, Steinbrecher K, et al. Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6Chigh CCR2+ inflammatory monocyte/macrophage-derived CCL11. J Immunol 2011;186:5993-6003.
11. Zigmond E, Varol C, Farache J, et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 2012;37:1076-90.
12. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-41.
13. Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 2007;7:93-104.
14. Izawa K, Yamanishi Y, Maehara A, et al. The receptor LMIR3 negatively regulates mast cell activation and allergic responses by binding to extracellular ceramide. Immunity 2012;37:827-39.
15. Nakahashi-Oda C, Tahara-Hanaoka S, Shoji M, et al. Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor. J Exp Med 2012;209:1493-503.
16. Colonna M. TREMs in the immune system and beyond. Nat Rev Immunol 2003;3:445-53.
17. Chung DH, Humphrey MB, Nakamura MC, et al. CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. J Immunol 2003;171:6541-8.
18. Izawa K, Kitaura J, Yamanishi Y, et al. Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3. J Biol Chem 2007;282:17997-8008.
19. Grimbaldeston MA, Chen CC, Piliponsky AM, et al. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 2005;167:835-48.
20. Kitaura J, Song J, Tsai M, et al. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc Natl Acad Sci USA 2003;100:12911-16.
21. Weigmann B, Tubbe I, Seidel D, et al. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat Protoc 2007;2:2307-11.
22. Surprenant A, North RA. Signaling at purinergic P2X receptors. Annu Rev Physiol 2009;71:333-59.
23. Furuno T, Teshima R, Kitani S, et al. Surface expression of CD63 antigen (AD1 antigen) in P815 mastocytoma cells by transfected IgE receptors. Biochem Biophys Res Commun 1996;219:740-4.
24. Moshkovits I, Shik D, Itan M, et al. CMRF35-like molecule 1 (CLM-1) regulates eosinophil homeostasis by suppressing cellular chemotaxis. Mucosal Immunol 2014;7:292-303.
25. Masterson JC, McNamee EN, Fillon SA, et al. Eosinophil-mediated signaling attenuates inflammatory responses in experimental colitis. Gut 2015;64:1236-47.
26. Choi SC, Simhadri VR, Tian L, et al. Cutting edge: mouse CD300f (CMRF-35-like molecule-1) recognizes outer membrane-exposed phosphatidylserine and can promote phagocytosis. J Immunol 2011;187:3483-7.